These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20701468)

  • 41. Evaluation of the diagnostic value of the first-trimester maternal serum high-sensitivity C-reactive protein level for prediction of pre-eclampsia.
    Kashanian M; Aghbali F; Mahali N
    J Obstet Gynaecol Res; 2013 Dec; 39(12):1549-54. PubMed ID: 23875844
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Changes in circulating level of IGF-I and IGF-binding protein-1 from the first to second trimester as predictors of preeclampsia.
    Vatten LJ; Nilsen TI; Juul A; Jeansson S; Jenum PA; Eskild A
    Eur J Endocrinol; 2008 Jan; 158(1):101-5. PubMed ID: 18166823
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased serum heat-shock protein 70 levels reflect systemic inflammation, oxidative stress and hepatocellular injury in preeclampsia.
    Molvarec A; Rigó J; Lázár L; Balogh K; Makó V; Cervenak L; Mézes M; Prohászka Z
    Cell Stress Chaperones; 2009 Mar; 14(2):151-9. PubMed ID: 18686014
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Levels of C-reactive protein in pregnant women who subsequently develop pre-eclampsia.
    Savvidou MD; Lees CC; Parra M; Hingorani AD; Nicolaides KH
    BJOG; 2002 Mar; 109(3):297-301. PubMed ID: 11950185
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correlation of CRP levels in third trimester with fetal birth weight in preeclamptic and normotensive pregnant women.
    Ali Z; Bokhari FA; Zaki S; Zargham U; Tauseef A; Khakan S
    J Coll Physicians Surg Pak; 2015 Feb; 25(2):111-4. PubMed ID: 25703754
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Retinol-Binding Protein 4 and Lipids Prospectively Measured During Early to Mid-Pregnancy in Relation to Preeclampsia and Preterm Birth Risk.
    Mendola P; Ghassabian A; Mills JL; Zhang C; Tsai MY; Liu A; Yeung EH
    Am J Hypertens; 2017 Jun; 30(6):569-576. PubMed ID: 28338737
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Second-trimester maternal serum inhibin A concentration as an early marker for preeclampsia.
    Aquilina J; Barnett A; Thompson O; Harrington K
    Am J Obstet Gynecol; 1999 Jul; 181(1):131-6. PubMed ID: 10411808
    [TBL] [Abstract][Full Text] [Related]  

  • 48. C-reactive protein, interleukin-6 and pre-eclampsia: large-scale evidence from the GenPE case-control study.
    Serrano NC; Guio E; Becerra-Bayona SM; Quintero-Lesmes DC; Bautista-Niño PK; Colmenares-Mejía C; Páez MC; Luna ML; Díaz LA; Ortiz R; Beltrán M; Monterrosa Á; Miranda Y; Mesa CM; Saldarriaga W; Casas JP
    Scand J Clin Lab Invest; 2020 Sep; 80(5):381-387. PubMed ID: 32400228
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Angiogenic factors for the prediction of preeclampsia in high-risk women.
    Moore Simas TA; Crawford SL; Solitro MJ; Frost SC; Meyer BA; Maynard SE
    Am J Obstet Gynecol; 2007 Sep; 197(3):244.e1-8. PubMed ID: 17826405
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsia.
    Lynch AM; Murphy JR; Byers T; Gibbs RS; Neville MC; Giclas PC; Salmon JE; Holers VM
    Am J Obstet Gynecol; 2008 Apr; 198(4):385.e1-9. PubMed ID: 18221926
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Raised C-reactive protein and impaired flow-mediated vasodilation precede the development of preeclampsia.
    García RG; Celedón J; Sierra-Laguado J; Alarcón MA; Luengas C; Silva F; Arenas-Mantilla M; López-Jaramillo P
    Am J Hypertens; 2007 Jan; 20(1):98-103. PubMed ID: 17198919
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Periodontal disease, oxidative stress, and risk for preeclampsia.
    Horton AL; Boggess KA; Moss KL; Beck J; Offenbacher S
    J Periodontol; 2010 Feb; 81(2):199-204. PubMed ID: 20151797
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Short- and long-term changes in plasma inflammatory markers associated with preeclampsia.
    Freeman DJ; McManus F; Brown EA; Cherry L; Norrie J; Ramsay JE; Clark P; Walker ID; Sattar N; Greer IA
    Hypertension; 2004 Nov; 44(5):708-14. PubMed ID: 15452036
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of fibrinogen and C-reactive protein with severity of preeclampsia.
    Ustün Y; Engin-Ustün Y; Kamaci M
    Eur J Obstet Gynecol Reprod Biol; 2005 Aug; 121(2):154-8. PubMed ID: 16054955
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antiphospholipid antibodies in women at risk for preeclampsia.
    Branch DW; Porter TF; Rittenhouse L; Caritis S; Sibai B; Hogg B; Lindheimer MD; Klebanoff M; MacPherson C; VanDorsten JP; Landon M; Paul R; Miodovnik M; Meis P; Thurnau G;
    Am J Obstet Gynecol; 2001 Apr; 184(5):825-32; discussion 832-4. PubMed ID: 11303189
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interleukin-22: biomarker of maternal and fetal inflammation?
    Bersani I; De Carolis MP; Foell D; Weinhage T; Rossi ED; De Carolis S; Rubortone SA; Romagnoli C; Speer CP
    Immunol Res; 2015 Feb; 61(1-2):4-10. PubMed ID: 25407645
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An analysis on the roles of angiogenesis-related factors including serum vitamin D, soluble endoglin (sEng), soluble fms-like tyrosine kinase 1 (sFlt1), and vascular endothelial growth factor (VEGF) in the diagnosis and severity of late-onset preeclampsia.
    Cim N; Kurdoglu M; Ege S; Yoruk I; Yaman G; Yildizhan R
    J Matern Fetal Neonatal Med; 2017 Jul; 30(13):1602-1607. PubMed ID: 27658884
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Failure of serum beta2-microglobulin levels as an early marker of preeclampsia.
    Haddad B; Desvaux D; Livingston JC; Barranger E; Paniel BJ; Sibai BM
    Am J Obstet Gynecol; 2000 Mar; 182(3):595-8. PubMed ID: 10739513
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Baseline placental growth factor levels for the prediction of benefit from early aspirin prophylaxis for preeclampsia prevention.
    Moore GS; Allshouse AA; Winn VD; Galan HL; Heyborne KD
    Pregnancy Hypertens; 2015 Oct; 5(4):280-6. PubMed ID: 26597741
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Maternal total cell-free DNA in preeclampsia and fetal growth restriction: Evidence of differences in maternal response to abnormal implantation.
    Rafaeli-Yehudai T; Imterat M; Douvdevani A; Tirosh D; Benshalom-Tirosh N; Mastrolia SA; Beer-Weisel R; Klaitman V; Riff R; Greenbaum S; Alioshin A; Rodavsky Hanegbi G; Loverro G; Catalano MR; Erez O
    PLoS One; 2018; 13(7):e0200360. PubMed ID: 30001403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.